Express Certificate USD Pfizer Express 2Sustainable certificate The product related information contained herein is exclusively for information purposes only, intended for current investors or in case these products are displayed further to an individual search. The information does not constitute a recommendation or an offer to buy or an invitation to make a respective offer in relation to any of the products described herein.

Bid90.71%
Oct 05, 2022 17:59:59.922 UTC
Ask92.21%
Oct 05, 2022 17:59:59.922 UTC
chg. 1D-0.900 (-0.97%)
Oct 05, 2022 17:59:59.922 UTC
Underlying price (indicative) 44.11 (-0.77%)
Oct 05, 2022 20:00:01.000 UTC
Starting value47.44 Next redemption level47.44 Max. yield p.a. until next observation date52.75%

Name
USD Pfizer Express 2
ISIN / WKN
AT0000A2VDC2 / RC05P2
Underlying
Sustainability preference
Consideration of Principal Adverse Impacts (PAI)
Underlying price (indicative)
USD 44.11 (-0.77%)
Oct 05, 2022 20:00:01.000
Starting value
USD 47.44
Barrier
USD 28.46
Distance to barrier
35.48%
Observation barrier
on the final valuation date
(early) redemption level
47.44 / 47.44 / 47.44 / 47.44 / 47.44
Distance to next termination level
-7.54%
(early) redemption amount
110.00% / 120.00% / 130.00% / 140.00% / 150.00%
Max. yield until next observation date
19.29%
Max. yield p.a. until next observation date
52.75%
No. of shares
21.07926
About the term

Initial valuation date
Mar 08, 2022
Issue date
Mar 09, 2022
Valuation dates
Mar 07, 2023 / Mar 07, 2024 / Mar 06, 2025 / Mar 05, 2026 / Mar 04, 2027
Final valuation date
Mar 04, 2027
Maturity date
Mar 10, 2027

Product classification
Investment Product without Capital Protection
Security type (Eusipa No.)
Express Certificate (1260)
Express Certificate Type
Express Certificate
Underlying
Country / region of underlying
USA
Suited market expectation
sideways, bullish
Spread homogenised
0.71
Spread (in %)
1.65%
Multiplier
-
Product currency
USD
Underlying currency
USD
Settlement method
Cash settlement / Physical delivery
Taxation
Capital Gains Tax / no Foreign Capital Gains Tax
Public offer possible in
Austria, Germany, Italy, Hungary, Poland, Czech Republic, Slovakia, Bulgaria, Croatia, Romania, Slovenia
Listing
Stuttgart
Description

This certificate provides the opportunity for early redemption each year and enables investors to obtain a yield of 10% per year if the price of the Pfizer share quotes on one of the annual valuation days at or above the termination level. In case the share price quotes below the respective termination level, the term will be extended by another year ¿ up to a maximum of 5 years. If the barrier is violated at the end of the term, the investor is entirely subject to market risk.

This certificates complies with RCB's sustainability standards.

TRADING HOURS
Products on Austrian underlyings9:15 am - 5:30 pm

Products on underlyings of CEE, Eastern Europe and Turkey

 

 - Turkey, Czech Republic9:00 am - 4:00 pm
 - Russia, Croatia, Ukraine, Kazakhstan9:15 am - 4:30 pm
 - Poland, Hungary, Romania, CEE and Eastern Europe9:15 am - 4:50 pm
  
Products on other international underlyings and commodities
(incl. Germany and Switzerland)
9:00 am - 8:00 pm
INFORMATION

Monday - Friday
8:00 am to 5:30 pm


T: +43151520484
F: +431 51520-200
E: produkte(at)rcb.at